gogo
Amazon cover image
Image from Amazon.com

Psychiatric drugs explained / David Healy.

By: Material type: TextTextPublication details: Edinburgh : Churchill Livingstone, 2009.Edition: 5th edDescription: 344 p. : illISBN:
  • 9780702029974 (pbk.) :
  • 9780702029974 (pbk.) :
Subject(s): DDC classification:
  • 615.788 HEA
  • 615.78 22
LOC classification:
  • RM315
Contents:
1. Introduction: Section 1. Management of psychoses:- 2. Antipsychotics--3. Antipsychotic side effects and their management--References--Section 2 --Management of depression:- 4. Antidepressants--5. Side effects of antidepressants--References--Section 3. Management of bipolar disorders:- 6. Management of acute bipolar disorder--7. Mood-stabilisers--References--Section 4. Drugs for children:-8. Drugs for children--References--Section 5. Management of anxiety:- 9. Anxiety disoders--10. Benzodiazepine anxiolytics--11. Anxiolysis and the serotonin system--12. Beta-blockers and anxiety--References--Section 6. Management of sleep disorders and insomnia:- 13. Sleep disorders and insomnia--14. Non-pharmacological management of insomnis--15. Hypnotics--16. Sedatives--References--Section 7: Management of cognitive impairment:- 17. Cognitive enhancement and the dementias--18. Cognitive enhancement and neuroprotection--References--Section 8. Management of sexual difficulties:- 19. The range of sexual difficulties--20. Effects of drugs on aspects of sexual functioning--Appendix 20.1: Male sexual functioning questionnaire--Appendix 20.2: Female sexual functioning questionnaire--References--Section 9. Management of dependence and withdrawal:- 21. Physical dependence type 1--22. Physical dependence type 2--23. Physical dependence type 3--References--Section 10: Consent, abuse and liability:- 24. Consent--25. Pharmacological abuse--26. Liability--References--Section 11: The marketing of tranquility:- 27. The ethical industry--28. Evidence-based psychiatry--29. The marketing of psychiatric disorders--30. From health care to Pharmageddon--References.
Summary: This text provides drug names in generic as well as both UK and US tradenames. In addition to a comprehensive review of drug treatment organised by condition, the text also addresses important issues for professionals and their clients concerning consent, liability and the management of side effects and withdrawal.
Holdings
Item type Current library Call number Copy number Status Date due Barcode
Long Loan TUS: Midlands, Main Library Athlone Nursing Collection 615.788 HEA (Browse shelf(Opens below)) 1 Available 208689
Short Loan TUS: Midlands, Main Library Athlone Nursing Collection 615.788 HEA (Browse shelf(Opens below)) 1 Available 208688

Previous ed.: Edinburgh: Elsevier Churchill Livingston, 2005.

Formerly CIP. Uk

Includes bibliographical references and index.

1. Introduction: Section 1. Management of psychoses:- 2. Antipsychotics--3. Antipsychotic side effects and their management--References--Section 2 --Management of depression:- 4. Antidepressants--5. Side effects of antidepressants--References--Section 3. Management of bipolar disorders:- 6. Management of acute bipolar disorder--7. Mood-stabilisers--References--Section 4. Drugs for children:-8. Drugs for children--References--Section 5. Management of anxiety:- 9. Anxiety disoders--10. Benzodiazepine anxiolytics--11. Anxiolysis and the serotonin system--12. Beta-blockers and anxiety--References--Section 6. Management of sleep disorders and insomnia:- 13. Sleep disorders and insomnia--14. Non-pharmacological management of insomnis--15. Hypnotics--16. Sedatives--References--Section 7: Management of cognitive impairment:- 17. Cognitive enhancement and the dementias--18. Cognitive enhancement and neuroprotection--References--Section 8. Management of sexual difficulties:- 19. The range of sexual difficulties--20. Effects of drugs on aspects of sexual functioning--Appendix 20.1: Male sexual functioning questionnaire--Appendix 20.2: Female sexual functioning questionnaire--References--Section 9. Management of dependence and withdrawal:- 21. Physical dependence type 1--22. Physical dependence type 2--23. Physical dependence type 3--References--Section 10: Consent, abuse and liability:- 24. Consent--25. Pharmacological abuse--26. Liability--References--Section 11: The marketing of tranquility:- 27. The ethical industry--28. Evidence-based psychiatry--29. The marketing of psychiatric disorders--30. From health care to Pharmageddon--References.

This text provides drug names in generic as well as both UK and US tradenames. In addition to a comprehensive review of drug treatment organised by condition, the text also addresses important issues for professionals and their clients concerning consent, liability and the management of side effects and withdrawal.

Powered by Koha